qa:qa_dcx-login
Xpert® TV
Fast and Accurate Diagnosis of Trichomoniasis in 90 minutes or less
Sign in or create a MyCepheid account to add items to cart
Test pack size(s)
10 Tests
GXTV-10
Qty
Unit price
Subtotal
USD
Product is not available for purchase in your region.
Collection devices
Swab Specimen Collection Kit (Pack of 50)
SWAB/G-50
Qty
Unit price
Subtotal
USD
Product is not available for purchase in your region.
Urine Collection Kit (Pack of 50)
URINE/A-50
Qty
Unit price
Subtotal
USD
Product is not available for purchase in your region.
Total
{{currency}}
0
Error adding items to cart. If this error persists, please contact Digital Support
The Need
Trichomoniasis, chlamydia, and gonorrhea are the three most prevalent, treatable STDs in the U.S. If left untreated, complications can include infertility, pelvic inflammatory disease, pregnancy complications, and increased risk of HIV acquisition.1
CDC recommends:1
CDC recommends:1
- Annual CT/NG screening of all sexually active women under 25
- Screening of other at-risk individuals including MSM*
- Testing for chlamydia, gonorrhea, & trichomoniasis using NAATs^ (PCR)
- Same-day testing and treatment
* MSM — men who have sex with men
^ NAAT — nucleic acid amplification test
^ NAAT — nucleic acid amplification test
The Solution
Accurate on-demand PCR results are ready when you need them
- On-demand and in-visit results reduce patient call-backs, overtreatment, undertreatment and patients lost to follow-up
- Patient collected specimens can create operational efficiencies
- Same patient sample can be utilized for all tests
The Impact
Provide fast patient results to:
- Lessen patient anxiety with immediate results
- Improve patient satisfaction
- Prevent disease spread in the community
- Reduce unnecessary use of antibiotics
2 David Soper, MD, Trichomoniasis: Under control or undercontrolled?, 2004, American Journal of Obstetrics and Gynecology (2004) 190, 281e90.
Related Products
Xpert HPV
Test Reliable Detection of High-Risk HPV DNA with Genotyping of HPV 16 and 18/45
Xpert CT/NG
90-minute detection and differentiation of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG)
Product Resources
Product Information
Package Inserts & MSDS
Frequently Asked Questions
Xpert TV is a qualitative in vitro diagnostic test for the detection of Trichomonas vaginalis genomic DNA. The test utilizes automated real-time PCR to amplify and detect Trichomonas vaginalis genomic DNA. (1)
The Xpert TV test uses female and male urine specimens, endocervical swab specimens, or patient-collected vaginal swab specimens (collected in a clinical setting). The Xpert TV test is intended to aid in the diagnosis of trichomoniasis (TV) in symptomatic or asymptomatic individuals. (1)
The protozoan Trichomonas vaginalis is responsible for trichomoniasis, which is a common sexually transmitted infection that can infect both men and women. There are 7.4 million cases of trichomoniasis annually in the United States. Trichomoniasis can be symptomatic or asymptomatic. (1)
In women, trichomoniasis is one of a range of conditions that may include vaginal discharge. Symptoms in females can include itching, burning, redness, or soreness of the genitals, unusual odor, discomfort with urination, or a thin clear, white, yellow, or green discharge. (2) In men, trichomoniasis may cause non-gonococcal urethritis (NGU). Symptoms in males can include itching or burning inside the penis, burning after ejaculation or urination, or penile discharge. (1)
For women, consider screening those receiving care in high-prevalence settings (e.g., STI clinics and correctional facilities) and for asymptomatic women at high risk for infection (e.g., women with multiple sex partners, transactional sex, drug misuse, or a history of STI or incarceration). For persons with HIV, screening is recommended for sexually active women at entry to care and at least annually thereafter. (2)
References
1.Cepheid. Xpert TV Package Insert. Accessed Dec. 18, 2023. https://www.cepheid.com/en-USntent/dam/www-cepheid-com/documents/package-insert-files/Xpert-TV-ENGLISH-Package-Insert-301-2887-Rev.%20D.pdf
2.CDC. Screening Recommendations and Considerations Referenced in Treatment Guidelines and Original Sources. June 6, 2022. Accessed Dec. 18, 2023. https://www.cdc.gov/std/treatment-guidelines/screening-recommendations.htm